R. Singh

发表

Network meta-analysis and cost per responder of targeted Immunomodulators in the treatment of active psoriatic arthritis

V. Strand, J. Zhao, K. Betts, 2018, BMC Rheumatology.

Economic Burden of Switching to Different Biologic Therapies Among Tumor Necrosis Factor Inhibitor-Experienced Patients with Psoriatic Arthritis

K. Betts, J. Griffith, Yan Song, 2019, Rheumatology and Therapy.

Malignancy Assessment Using Gene Identification in Captured Cells Algorithm for the Prediction of Malignancy in Women With a Pelvic Mass

Richard G. Moore, M. Miller, David Englert, 2022, Obstetrics and gynecology.

The risk of cardiovascular events in psoriasis patients treated with tumor necrosis factor–&agr; inhibitors versus phototherapy: An observational cohort study

M. Sundaram, A. Ganguli, Jashin J. Wu, 2018, Journal of the American Academy of Dermatology.

The Comorbidity Burden of Hidradenitis Suppurativa in the United States: A Claims Data Analysis

A. Kimball, I. Pivneva, M. Sundaram, 2018, Dermatologic Therapy.

Comparison of US patient, rheumatologist, and dermatologist perceptions of psoriatic disease symptoms: results from the DISCONNECT study

A. Ganguli, M. Husni, B. Hauber, 2018, Arthritis Research & Therapy.

Prevalence of Psoriasis in Children and Adolescents in the United States: A Claims-Based Analysis.

A. Paller, A. Ganguli, M. Gauthier-Loiselle, 2018, Journal of drugs in dermatology : JDD.

Adverse Medical Conditions Across Treatment Options in Patients With Psoriasis: A Claims-Based Analysis

A. Armstrong, A. Fleischer, A. Ganguli, 2018, Journal of drugs in dermatology : JDD.

Disease activity and biologic use in patients with psoriatic arthritis or rheumatoid arthritis

J. Kremer, J. Greenberg, A. Kavanaugh, 2018, Clinical Rheumatology.